Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MALT1 | Q9UDY8 | 9/20 | 0.39 |
| ▸ | RBP4 | P02753 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL951639 | 0.84 | MALT1 (0.38) | MALT1PKM | |
| SCHEMBL1697025 | 0.84 | CYP1A2 (0.43) | POLBGAATSHRMALT1RBP4 | |
| SCHEMBL1697019 | 0.82 | CYP1A2 (0.40) | POLBGAATSHRMALT1RBP4 | |
| SCHEMBL15050935 | 0.79 | GABRA2 (0.42) | POLBGAATSHRMALT1RBP4 | |
| SCHEMBL23249321 | 0.78 | DHODH (0.45) | POLBGAATSHRMALT1RBP4 | |
| SCHEMBL29504162 | 0.78 | DHODH (0.45) | POLBGAATSHRMALT1RBP4 | |
| SCHEMBL12528531 | 0.76 | TRPV1 (0.40) | MALT1CYP1A2ALDH1A1 | |
| SCHEMBL12559368 | 0.75 | ALDH1A1 (0.36) | GAAMALT1RBP4ALDH1A1HTT | |
| SCHEMBL13318581 | 0.75 | ALDH1A1 (0.38) | MALT1RBP4ALDH1A1 | |
| SCHEMBL12528877 | 0.74 | MALT1 (0.34) | POLBMALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2582691-B1 | ANTHRANILIC ACID DERIVATIVES | BAYER IP GMBH (DE) | 2017-05-10 | — | — | EP | disclosed |
| EP-2582688-B1 | ANTHRANILIC ACID DIAMIDE DERIVATIVES | BAYER IP GMBH (DE) | 2015-10-07 | — | — | EP | disclosed |
| US-8980886-B2 | Anthranilic acid derivatives | BAYER CROPSCIENCE AG (DE) | 2015-03-17 | — | — | US | disclosed |
| US-8791139-B2 | Anthranilic diamide derivatives | BAYER CROPSCIENCE AG (DE) | 2014-07-29 | — | — | US | disclosed |
| US-20130165483-A1 | HETEROARYLS AND USES THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2013-06-27 | — | — | US | disclosed |
| US-20130165483-A1 | HETEROARYLS AND USES THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2013-06-27 | — | — | US | disclosed |
| US-20130165483-A1 | HETEROARYLS AND USES THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2013-06-27 | — | — | US | disclosed |
| WO-2013096637-A1 | HETEROARYLS AND USES THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2013-06-27 | — | — | WO | disclosed |
| CN-103068814-A | Anthranilic acid derivatives | BAYER CROPSCIENCE AG | 2013-04-24 | — | — | CN | disclosed |
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-01-19 | — | — | US | disclosed |
| US-20110312953-A1 | ANTHRANILIC ACID DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165483-A1 | HETEROARYLS AND USES THEREOF | PIK3R5, PIK3R4, PIK3C2B | POLB 1101/4885GAA 129/4885TSHR 3903/4885 |
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | DDT, QDPR, ANTXR2 | POLB 4330/4885GAA 426/4885TSHR 1329/4885 |
| US-20110312953-A1 | ANTHRANILIC ACID DERIVATIVES | ANTXR2, NQO2, ACLY | POLB 3603/4885GAA 185/4885TSHR 1504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.